SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,540.00    90.00 (2.02%)
Bid:
4,500.00
Ask:
4,580.00
Spread: 80.00 (1.778%)
Market Cap: £302.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

18 Jul 2012 07:00

RNS Number : 8953H
Judges Scientific PLC
18 July 2012
 

 

 

Judges Scientific plc

Trading Statement

18 July 2012

Judges Scientific plc ('Judges Scientific', the 'Company' or the 'Group')

Trading Update

The Directors of Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, are pleased to update shareholders and the market with regard to the Group's trading performance during the first half of the current financial year.

The Group recorded a solid trading performance during the period to 30 June 2012. The interim results, scheduled to be announced in September, are expected to show organic revenue growth of almost 8% compared with the six months to 30 June 2011. This advance in revenue increases to 39% when account is taken of businesses purchased since 1 January 2011, including a full six months of turnover from Deben and a first time contribution from Global Digital Systems ("GDS") and KE Developments ("KED"). The Board anticipates that interim profits and earnings per share before exceptional items will reflect this satisfactory performance.

GDS and KED were acquired on 6 March 2012 and both have since traded in line with management's expectations. The KED business was successfully relocated into Deben's Woolpit premises during the course of June 2012.

Order intake during the six-month period showed organic growth of 14%. The order book at 30 June 2012 represented ten weeks of sales, somewhat ahead of the level at the beginning of the year, partly as a result of the strong order intake and partly due to the fact that GDS's order book tends to be longer than the Group average.

The balance sheet will show a comfortable cash surplus as at 30 June 2012. Net debt had been eliminated altogether by the end of February, before £8.0 million was borrowed in March to finance the acquisition of GDS. However, the share placing in May raised £2.8 million (net) and this can be assumed to have reduced the level of gearing to less than one-times pro-forma historic EBITA.

The Board continues to be mindful that the global economic climate is fraught with uncertainty. Public spending restraint in Europe, the strength of Sterling, the embattled status of the Euro and fears of deceleration in China are all factors which are capable of affecting our businesses. There can be no complacency and the Board views the current trading environment with balanced measures of vigilance and confidence.

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Edwards Mansfield, Shore Capital: Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMNRNRGZZM
Date   Source Headline
13th Dec 20164:11 pmRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSAcquisition of EWB Solutions Ltd
21st Nov 20165:40 pmRNSBlock listing Interim Review
9th Nov 20164:38 pmRNSDirector/PDMR Shareholding
9th Nov 20164:35 pmRNSDirector/PDMR Shareholding
9th Nov 20164:32 pmRNSDirector/PDMR Shareholding
20th Oct 20164:21 pmRNSHolding(s) in Company
17th Oct 20162:47 pmRNSHolding(s) in Company
7th Oct 20163:30 pmRNSDirector/PDMR Shareholding
7th Oct 20163:20 pmRNSDirector/PDMR Shareholding
7th Oct 20163:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20167:00 amRNSTotal Voting Rights
20th Sep 20167:00 amRNSInterim Results
12th Sep 20162:50 pmRNSDirector/PDMR Shareholding
12th Sep 20162:30 pmRNSDirector/PDMR Shareholding
31st Aug 20167:00 amRNSTotal Voting Rights
10th Aug 20162:30 pmRNSDirector/ PDMR Shareholding
10th Aug 20162:30 pmRNSDirector/ PDMR Shareholding
9th Aug 20167:00 amRNSNotice of Results
29th Jul 201611:05 amRNSTR-1: Notification of Major Interest in Shares
26th Jul 20161:30 pmRNSDirector/PDMR Shareholding
20th Jul 20167:00 amRNSTrading Update
8th Jul 201610:20 amRNSDirector/PDMR Shareholding
29th Jun 20165:35 pmRNSDirector/PDMR Shareholding
8th Jun 20161:40 pmRNSDirector/ PDMR Shareholding
1st Jun 20167:00 amRNSTotal Voting Rights
25th May 20161:05 pmRNSResult of Annual General Meeting
25th May 20167:00 amRNSAGM Statement
16th May 20169:31 amRNSBlock listing Interim Review
9th May 20164:00 pmRNSDirector/PDMR Shareholding
5th May 20168:53 amRNSHolding(s) in Company
3rd May 20167:00 amRNSTotal Voting Rights
13th Apr 201611:32 amRNSDirector/PDMR Shareholding
7th Apr 20165:05 pmRNSDirector/ PDMR Shareholding
1st Apr 20162:28 pmRNSDirector/PDMR Shareholding
1st Apr 20167:00 amRNSAcquisition of Dia-Stron Limited
29th Mar 20167:00 amRNSAcquisition
22nd Mar 20167:00 amRNSFinal Results
9th Mar 20164:06 pmRNSDirector/PDMR Shareholding
8th Mar 20163:03 pmRNSHolding(s) in Company
1st Mar 20167:00 amRNSTotal Voting Rights
25th Feb 20162:00 pmRNSDividend Declaration
19th Feb 20164:31 pmRNSHolding(s) in Company
19th Feb 20164:29 pmRNSHolding(s) in Company
18th Feb 20167:00 amRNSAcquisition of CoolLED Limited
10th Feb 20162:11 pmRNSDirector/PDMR Shareholding
19th Jan 20167:00 amRNSTrading Statement and Notice of Results
7th Jan 20161:53 pmRNSDirector/PDMR Shareholding
9th Dec 20154:32 pmRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.